Gene Editing Stocks Are Set to Explode. Here's Why.
7:37
CRISPR's Next Advance Is Bigger Than You Think | Jennifer Doudna | TED
53:19
Before The Mets, Steve Cohen Was The Hedge-Fund King (full documentary) | FRONTLINE
55:04
Building A Biotech Hub With Intellia Therapeutics' John Leonard, M.D.
18:34
This Time It's Different
17:58
How to Build A Great Dividend Portfolio
55:36
Fim da estrada: como o dinheiro se tornou inútil
5:27
CRISPR Therapeutics CEO talks winning FDA approval for sickle cell anemia treatment
3:00:55